Skip to main content
. 2018 Jun 18;9:1355. doi: 10.3389/fimmu.2018.01355

Table 3.

Proportion of patients with Grades 1–5 toxicities attributed to ch14.18 on COG study ANBL0931.

Pain (%) Allergic reactions (%) Capillary leak syndrome (%) Hypotension (%) Fever (%) Ocular toxicity (%)
Course 1 (n = 104) 93 25 24 60 91 2
Course 2 (n = 100) 78 28 39 64 92 3
Course 3 (n = 98) 79 16 14 58 69 3
Course 4 (n = 90) 77 21 33 69 87 1
Course 5 (n = 88) 70 13 17 52 67 1
Course 6 (n = 81) 26 0 0 14 19 0